Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Emilia M Jalilfor Transcender Study Team

Abstract

HIV epidemics disproportionately affect transwomen worldwide. Trans-specific guidance, outreach, and interventions to increase pre-exposure prophylaxis (PrEP) use among transwomen are scarce. Rio de Janeiro, Brazil. We measured awareness and willingness to use PrEP and examined factors associated with those outcomes among transwomen in Rio de Janeiro and estimated how many transwomen would be eligible for PrEP. Data originate from Transcender study, a respondent-driven sampling survey conducted from August 2015 to January 2016. We performed regression models for PrEP awareness and willingness. One hundred thirty-one (38.0%) of 345 participants had heard of PrEP. Among transwomen who self-reported as HIV-negative, 162 (76.4%, N = 212 with available data) reported willingness to use it and 163 (66.8%, N = 244) met PrEP behavioral eligibility criteria. Transwomen with health access in the previous 6 months who reported HIV-infected sexual partner and with 8+ years of schooling had increased odds of PrEP awareness. Lower PrEP awareness was associated with condomless anal intercourse and newly diagnosed HIV infection. Younger age and perceiving themselves at risk of HIV infection increased the odds of PrEP willingness. Lower odds of...Continue Reading

References

Jan 24, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Norma C WareDavid R Bangsberg
Dec 25, 2012·The Lancet Infectious Diseases·Stefan D BaralChris Beyrer
Mar 23, 2013·Social Science & Medicine·Tonia PoteatDeanna Kerrigan
May 17, 2014·Arquivos brasileiros de endocrinologia e metabologia·Elaine Maria Frade Costa, Berenice Bilharinho Mendonca
Nov 19, 2014·Journal of Endocrinological Investigation·B FabrisC Trombetta
Jul 23, 2015·Journal of the International AIDS Society·Valdilea G VelosoBeatriz Grinsztejn
Nov 29, 2015·The Lancet. HIV·Madeline B DeutschUNKNOWN iPrEx investigators
Apr 30, 2016·The Lancet. HIV·Erin C WilsonBeatriz Grinsztejn
Jul 20, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Tonia PoteatStefan Baral
Oct 21, 2016·Journal of the International AIDS Society·Jae M SeveliusRobert Grant
Jan 20, 2017·Prevention Science : the Official Journal of the Society for Prevention Research·Lisa A EatonUNKNOWN POWER Study Team
Feb 12, 2017·The Lancet. HIV·Beatriz GrinsztejnUNKNOWN Transcender Study Team
Jul 26, 2017·Journal of the International AIDS Society·Bridget L DraperMark Stoové
Aug 9, 2017·American Journal of Public Health·H Fisher RaymondWilli McFarland
Sep 2, 2017·Transgender Health·Virginia ZalazarM Eugenia Socías
Oct 20, 2017·American Journal of Public Health·Sarah K CalabreseKenneth H Mayer

❮ Previous
Next ❯

Citations

Jun 21, 2019·Current Opinion in HIV and AIDS·Tonia PoteatSari Reisner
Oct 22, 2019·Global Public Health·César Torres-Cruz, Edna Suárez-Díaz
Jun 11, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Tonia PoteatThespina Yamanis
Apr 23, 2020·Expert Review of Anti-infective Therapy·Asa E RadixZil G Goldstein
Oct 24, 2020·International Journal of STD & AIDS·Gloria AguilarSergio Muñoz
Apr 11, 2021·Health and Quality of Life Outcomes·Thiago S TorresBrett D Thombs
Aug 15, 2021·AIDS and Behavior·Erin C WilsonWilli McFarland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.